Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma

Intern Med. 2021 Apr 1;60(7):1073-1076. doi: 10.2169/internalmedicine.5643-20. Epub 2020 Nov 9.

Abstract

We herein report a rare case of advanced lung adenocarcinoma with central diabetes insipidus due to pituitary metastasis. Although treatment with gefitinib was dramatically effective, the symptoms of diabetes insipidus did not improve. Radiotherapy for pituitary metastasis was effective to control diabetes insipidus; however, we could not cease the administration of 1-deamino-8-D-arginine vasopressin (DDAVP). It is important for physicians to positively consider radiotherapy for pituitary metastases even if favorable tumor control is achieved with chemotherapy when diabetes insipidus becomes clinically overt. Furthermore, continuous DDAVP administration may be needed to treat central diabetes insipidus.

Keywords: 1-deamino-8-D-arginine vasopressin; central diabetes insipidus; lung cancer; pituitary metastasis; radiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma of Lung* / complications
  • Adenocarcinoma of Lung* / drug therapy
  • Deamino Arginine Vasopressin / therapeutic use
  • Diabetes Insipidus* / drug therapy
  • Diabetes Insipidus* / etiology
  • Diabetes Insipidus, Neurogenic* / diagnosis
  • Diabetes Insipidus, Neurogenic* / drug therapy
  • Diabetes Insipidus, Neurogenic* / etiology
  • Diabetes Mellitus*
  • Gefitinib / therapeutic use
  • Humans
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / drug therapy

Substances

  • Deamino Arginine Vasopressin
  • Gefitinib